Investment group 3i acquires Belgian pharmaceutical company

The East Flanders-based pharmaceutical company Ixx Pharma has been acquired by the French group Havea, which is owned by Anglo-Saxon private equity giant 3i.

Havea’s rapid expansion in natural health products

Havea Group is a major player in the European market for natural health products, specializing in:

Nutritional supplements
Essential oils
Cosmetics and hygiene products
Herbal teas

Havea sells its products through pharmacies, retail stores, and online, including in Belgium.

With the backing of 3i, Havea has been rapidly expanding, both organically and through acquisitions. The takeover of Ixx Pharma marks its fifth acquisition in as many years, helping the group surpass €200 million in revenue and further strengthen its position in international pharmacy markets.

Ixx Pharma strengthens Havea’s supplement portfolio

With the acquisition of Ixx Pharma, Havea expands its footprint in the nutritional supplements market.

Ixx Pharma, based in Nieuwkerken-Waas, was founded in 2005 by scientists Danny Bral and René Zagers. The company has developed a wide range of nutritional supplements, which are produced in Belgium and Germany and sold through pharmacies in Belgium and Luxembourg.

A profitable and growing Belgian company

Ixx Pharma employs more than 20 people.
In 2022, it generated approximately €12 million in revenue.
The company is highly profitable, with a net profit of €1.1 million last year.
It added €3 million to its reserves from cumulative profits.

Full acquisition by Havea

Ixx Pharma was previously owned by Bral, Zagers, and a group of pharmacists.

As the company sought a partner for further expansion, Havea has now fully acquired Ixx Pharma, confirms co-founder René Zagers.

Source: De Tijd, Bert Broens, 1/09/2021, This is an automatically generated translation of the original article, Link to original article.